INOCELLS

inoCells has concluded its Preclinical and Phase I clinical studies with very positive results resulting in natural pregnancy and live birth of a child from a mother with 13 years of infertility and multiple rounds of failed IVF treatment. inoCells innovation is patent pending via multiple patents at the European Patent Office (EPO) and World Intellectual Property Organization (WIPO). inoCells product is classified as an Advanced Therapy Medicinal Product (ATMP) tissue engineered product by the European Medicine Agency (EMA). EMA has also confirmed and concluded that inoCells is addressing an Unmet Medical need. The product is produced under the ATMP Good Manufacturing Practice (GMP) guidelines. inoCells is located in Limburg with close proximity to the Dutch, Germany, French & Belgian Markets. Our therapy will be provided as a service to hospitals & IVF centers... inoCells provides a unique stem cell therapy and banking to rejuvenate the ovary of infertile patients whose ovaries have..

Primary location: Maastricht Netherlands